Shares of FIGS, Inc. (NYSE: FIGS) surged 17.29% in Thursday's trading session following the release of the company's impressive third-quarter 2025 financial results. The healthcare apparel maker significantly outperformed analyst expectations, demonstrating robust growth across key financial metrics and providing an optimistic outlook for the full year.

FIGS reported quarterly earnings of $0.05 per share, substantially beating the analyst consensus estimate of $0.02 by 212.5%. This represents a remarkable turnaround from the $0.01 loss per share reported in the same period last year. The company's revenue also exceeded expectations, coming in at $151.7 million, a 6.42% beat over the analyst consensus estimate of $142.5 million and an 8.2% increase from the previous year. The strong performance was attributed to higher orders from both new and existing customers, as well as an increased average order value, which rose 5.6% year-over-year to $114.

The company's core scrubwear segment showed solid growth, with net revenues reaching $127.0 million, up 8.4% from the same period last year. FIGS also reported a significant improvement in profitability, with net income surging to $8.7 million compared to a net loss of $1.7 million in the prior-year quarter. The adjusted EBITDA of $18.9 million and margin of 12.4% further underscore the company's operational efficiency. Looking ahead, FIGS raised its full-year 2025 outlook, projecting net revenue growth of about 7.0%, up from its previous forecast of low single-digit growth. This positive guidance, combined with the strong quarterly results, likely contributed to the significant stock price jump and renewed investor enthusiasm for FIGS.